Physician profile
Owen R Oneill
NPI 1568410454
$175,068.52
in general payments reported to CMS, 2019-2025
10 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $31K · 2021: $8,531 · 2022: $31K · 2023: $13K · 2024: $325 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $30K · Consulting Fee: $13K · Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $29,946.29 |
| Consulting Fee | $12,869.72 |
| Food and Beverage | $624.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $89,532.32 | 2019-2020 | |
| Medtronic, INC. | $34,832.43 | 2021-2024 | |
| Restor3d, INC. | $29,946.29 | 2025 | |
| Conformis, INC. | $18,635.31 | 2020-2023 | Identity Imprint Knee Replacement System, Actera Hip Stem |
| Responsive Arthroscopy INC | $909.40 | 2019-2025 | Responsive Arthroscopy Devices |
| Stryker Corporation | $688.23 | 2020-2024 | N/A |
| Zimmer Biomet Holdings, INC. | $240.04 | 2019-2022 | |
| Depuy Synthes Sales INC. | $173.48 | 2022 | |
| Smith+Nephew, INC. | $90.76 | 2021 | |
| Medical Device Business Services, INC. | $20.26 | 2025 | Velys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,076,438.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Owen Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.